101 Spam-Free Article(s) Found
Sort:
Date
Filter:
All
Symbol Name Last Close Mkt Cap DailyStocks'
Rating
Our DailyStocks’ Rating System is a proprietary algorithm that combines the vote of the investor community and legendary trader Richard Dennis’ Turtle Trader System and the System Rules of the Turtle Traders Each day, we generate Buy, Sell, Uptrend or Downtrend signals for 3000 Stocks in the U.S. Markets.
Vote Now!
Monday’s Close
EC Ecopetrol S.A. $25.79 $53.02B Sell
Article Searches
ExxonMobil Inks Contract for Oil Exploration in Block COL-4 http://www.zacks.com/stock/news/370552/exxonmobil-inks-contract-for-oil-exploration-in-block-col-4?cid=CS-ZC-FT-370552 Apr 04, 2019 - ExxonMobil (XOM) and Ecopetrol S.A. (EC) sign 50-50 joint contract with Repsol.
AstraZeneca's Forxiga Gets EC Approval for Type-I Diabetes http://www.zacks.com/stock/news/364120/astrazenecas-forxiga-gets-ec-approval-for-type-i-diabetes?cid=CS-ZC-FT-364120 Mar 25, 2019 - AstraZeneca's (AZN) diabetes drug gets approval in Europe for type-1 diabetes as an adjunct to insulin in patients with a BMI greater or equal to 27 kg/m2.
Regeneron, Sanofi Get EC Nod for Label Expansion of Praluent http://www.zacks.com/stock/news/360917/regeneron-sanofi-get-ec-nod-for-label-expansion-of-praluent?cid=CS-ZC-FT-360917 Mar 18, 2019 - Regeneron (REGN) and partner Sanofi receives approval in Europe for the label expansion of Praluent to reduce cardiovascular (CV) risk in adults with established atherosclerotic CV disease.
Roche Receives EC Approval for Label Expansion of Hemlibra http://www.zacks.com/stock/news/359564/roche-receives-ec-approval-for-label-expansion-of-hemlibra?cid=CS-ZC-FT-359564 Mar 14, 2019 - Roche (RHHBY) gets approval from European Commission for a label expansion of hemophilia drug, Hemlibra.
The Daily Biotech Pulse: Arsanis Completes X4 Merger, EC Nod For Roche, Axovant Offering http://feeds.benzinga.com/~r/benzinga/~3/luqnX1mkMuQ/the-daily-biotech-pulse-arsanis-completes-x4-merger-ec-nod-for-roche- Mar 14, 2019 -

Here's a roundup of top developments in the biotech space over the last 24 hours.

Scaling The Peaks

(Biotech stocks hitting 52-week highs on March 13)

read more

EC OK's Merck's Keytruda in first-line lung cancer https://seekingalpha.com/news/3442663-ec-oks-mercks-keytruda-first-line-lung-cancer?source=feed_news_all Mar 14, 2019 - As expected, the European Commision approves Merck's (NYSE:MRK) Keytruda (pembrolizumab), combined with carboplatin and Celgene's (NASDAQ:CELG) Abraxane (paclitaxel protein-bound), for the first-line
EC OK's expanded use for Roche's Hemlibra https://seekingalpha.com/news/3442658-ec-oks-expanded-use-roches-hemlibra?source=feed_news_all Mar 14, 2019 - The European Commission (EC) approves Roche's (OTCQX:RHHBY) Hemlibra (emicizumab) for routine prophylaxis of bleeding episodes in people with severe haemophilia A (congenital factor VIII defic
Roche's (RHHBY) Tecentriq Gets EC Nod for First-Line NSCLC http://www.zacks.com/stock/news/358374/roches-rhhby-tecentriq-gets-ec-nod-for-first-line-nsclc?cid=CS-ZC-FT-358374 Mar 08, 2019 - Roche (RHHBY) obtains approval for the label expansion of Tecentriq in Europe. The company also submits its sNDA for leukemia drug, Venclexta.
The Daily Biotech Pulse: Tonix Gets European Patent, EC Nod For Roche, Insys Earnings http://feeds.benzinga.com/~r/benzinga/~3/D7voBuYZzwY/the-daily-biotech-pulse-tonix-gets-european-patent-ec-nod-for-roche-i Mar 08, 2019 -

Here's a roundup of top developments in the biotech space over the last 24 hours:

Scaling The Peaks

(Biotech stocks hitting 52-week highs on March 7)

read more

Ecopetrol Allocates $500M of Capital Outlay for Fracking http://www.zacks.com/stock/news/358056/ecopetrol-allocates-%24500m-of-capital-outlay-for-fracking?cid=CS-ZC-FT-358056 Mar 07, 2019 - Ecopetrol (EC) is set to invest $500 million toward exploring unconventional deposits in the 2019-2021 time frame, beginning with shale pilot programs in Colombia???s shale-rich Magadalena Valley basin.

Pages: 123456...11

Page 1>